• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核RNA测序揭示了胶质母细胞瘤最常见亚型的临床前模型。

Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma.

作者信息

García-Vicente Laura, Martínez-Fernández María, Borja Michael, Tran Vanessa, Álvarez-Vázquez Andrea, Flores-Hernández Raquel, Ding Yuxin, González-Sánchez Raúl, Granados Alejandro, McGeever Erin, Kim Yang-Joon, Detweiler Angela, Mekonen Honey, Paul Sheryl, Pisco Angela O, Neff Norma F, Tabernero Arantxa

机构信息

Neuroscience Institute of Castile-Leon (INCYL), iBRAINS-IN-CyL, Department of Biochemistry and Molecular Biology, Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.

Chan Zuckerberg Biohub, San Francisco, USA.

出版信息

Commun Biol. 2025 Apr 28;8(1):671. doi: 10.1038/s42003-025-08092-x.

DOI:10.1038/s42003-025-08092-x
PMID:40295632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12037721/
Abstract

Different glioblastoma (GBM) subtypes have been identified based on the tumor microenvironment (TME). The discovery of new therapies for these hard-to-treat tumors requires a thorough characterization of preclinical models, including their TME, to apply preclinical results to the most similar GBM subtype. Using single-nucleus RNA sequencing (snRNA-seq), we characterized the tumor and TME in an immunocompetent mouse model with intracranially implanted GBM stem cells at different stages and treatments. Visium spatial transcriptomics confirmed the location of annotated cells. This model exhibits GBM targets related to integration into neural circuits - Grik2, Nlgn3, Gap43 or Kcnn4-, immunoevasion - Nt5e, Cd274 or Irf8- and immunosuppression - Csf1r, Arg1, Mrc1 and Tgfb1. The landscape of cytokines, checkpoint ligands and receptors uncovered Mrc1, PD-L1, TIM-3 or B7-H3, among the immunotherapy targets that can be addressed in this model. The comparison with human GBMs unveiled crucial similarities with TME GBM, the most frequent subtype.

摘要

基于肿瘤微环境(TME)已鉴定出不同的胶质母细胞瘤(GBM)亚型。要为这些难以治疗的肿瘤开发新疗法,需要全面表征临床前模型,包括其肿瘤微环境,以便将临床前结果应用于最相似的GBM亚型。我们使用单核RNA测序(snRNA-seq),对一个免疫活性小鼠模型中的肿瘤和肿瘤微环境进行了表征,该模型在不同阶段和治疗条件下颅内植入了GBM干细胞。Visium空间转录组学证实了注释细胞的位置。该模型展现出与整合到神经回路相关的GBM靶点——Grik2、Nlgn3、Gap43或Kcnn4,免疫逃逸靶点——Nt5e、Cd274或Irf8,以及免疫抑制靶点——Csf1r、Arg1、Mrc1和Tgfb1。细胞因子、检查点配体和受体图谱揭示了该模型中可针对的免疫治疗靶点,包括Mrc1、PD-L1、TIM-3或B7-H3。与人类GBM的比较揭示了与最常见的TME GBM亚型的关键相似之处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/7cf14c0c1ce7/42003_2025_8092_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/bb1458e95ef7/42003_2025_8092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/25e3efa4f17c/42003_2025_8092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/e947bbfa44d4/42003_2025_8092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/1a0deac90ab1/42003_2025_8092_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/53aa87f07d65/42003_2025_8092_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/180fbdff8a7b/42003_2025_8092_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/7cf14c0c1ce7/42003_2025_8092_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/bb1458e95ef7/42003_2025_8092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/25e3efa4f17c/42003_2025_8092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/e947bbfa44d4/42003_2025_8092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/1a0deac90ab1/42003_2025_8092_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/53aa87f07d65/42003_2025_8092_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/180fbdff8a7b/42003_2025_8092_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5399/12037721/7cf14c0c1ce7/42003_2025_8092_Fig7_HTML.jpg

相似文献

1
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma.单核RNA测序揭示了胶质母细胞瘤最常见亚型的临床前模型。
Commun Biol. 2025 Apr 28;8(1):671. doi: 10.1038/s42003-025-08092-x.
2
"Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.“放大”胶质母细胞瘤:单细胞 RNA 测序时代对肿瘤异质性及其临床意义的理解。
Neurosurgery. 2021 Feb 16;88(3):477-486. doi: 10.1093/neuros/nyaa305.
3
Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche.空间转录组学揭示了胶质母细胞瘤中肿瘤细胞状态的分离以及坏死周围微环境内显著的免疫抑制。
Acta Neuropathol Commun. 2024 Apr 22;12(1):64. doi: 10.1186/s40478-024-01769-0.
4
Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in Glioblastoma.单细胞转录组学揭示了胶质母细胞瘤中的免疫抑制微环境,并突出了促肿瘤巨噬细胞。
PLoS One. 2025 Apr 7;20(4):e0312764. doi: 10.1371/journal.pone.0312764. eCollection 2025.
5
The N-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma.N6-甲基腺苷修饰的假基因 HSPA7 与肿瘤微环境相关,并预测胶质母细胞瘤对免疫检查点治疗的反应。
Front Immunol. 2021 Jul 20;12:653711. doi: 10.3389/fimmu.2021.653711. eCollection 2021.
6
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.胶质母细胞瘤诱导的小胶质细胞在患者肿瘤和患者来源的原位异种移植物中向具有吞噬细胞和树突状细胞样特征的异质表型状态转变。
Genome Med. 2024 Apr 2;16(1):51. doi: 10.1186/s13073-024-01321-8.
7
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.从单细胞 lncRNA 表达分析中获得胶质母细胞瘤精准治疗的新见解。
J Cancer Res Clin Oncol. 2021 Jul;147(7):1881-1895. doi: 10.1007/s00432-021-03584-9. Epub 2021 Mar 11.
8
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.细胞外基质修饰增强胶质母细胞瘤溶瘤腺病毒免疫治疗。
Clin Cancer Res. 2021 Feb 1;27(3):889-902. doi: 10.1158/1078-0432.CCR-20-2400. Epub 2020 Nov 30.
9
Decoding glioblastoma's diversity: Are neurons part of the game?解码胶质母细胞瘤的多样性:神经元参与其中吗?
Cancer Lett. 2025 Jun 28;620:217666. doi: 10.1016/j.canlet.2025.217666. Epub 2025 Mar 25.
10
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.基于单细胞失巢凋亡调节因子模式探索BRMS1 +小胶质细胞在胶质母细胞瘤免疫微环境中的预后价值。
J Neurooncol. 2024 Oct;170(1):101-117. doi: 10.1007/s11060-024-04781-5. Epub 2024 Aug 15.

本文引用的文献

1
Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway.胶质瘤干细胞衍生的外泌体通过NEAT1/miR-125a/STAT3途径重塑胶质瘤相关巨噬细胞
Cancers (Basel). 2024 Jul 9;16(14):2500. doi: 10.3390/cancers16142500.
2
A proteomic approach supports the clinical relevance of TAT-Cx43 in glioblastoma.一种蛋白质组学方法支持 TAT-Cx43 在神经胶质瘤中的临床相关性。
Transl Res. 2024 Oct;272:95-110. doi: 10.1016/j.trsl.2024.06.001. Epub 2024 Jun 12.
3
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.
表皮生长因子受体扩增和 EGFRvIII 预测并参与了 TAT-Cx43266-283 在临床前胶质母细胞瘤模型中的抗肿瘤反应。
Neuro Oncol. 2024 Jul 5;26(7):1230-1246. doi: 10.1093/neuonc/noae060.
4
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.TIM-3 阻断在弥漫性内在脑桥胶质瘤模型中促进肿瘤消退和抗肿瘤免疫记忆。
Cancer Cell. 2023 Nov 13;41(11):1911-1926.e8. doi: 10.1016/j.ccell.2023.09.001. Epub 2023 Oct 5.
5
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.沃拉西尼布治疗 IDH1 或 IDH2 突变型低级别胶质瘤。
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
6
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.GAP43 依赖性线粒体从星形胶质细胞转移增强了神经胶质瘤的致瘤性。
Nat Cancer. 2023 May;4(5):648-664. doi: 10.1038/s43018-023-00556-5. Epub 2023 May 11.
7
The BAFF-APRIL System in Cancer.癌症中的BAFF-APRIL系统
Cancers (Basel). 2023 Mar 16;15(6):1791. doi: 10.3390/cancers15061791.
8
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.CD4 T 细胞对脑肿瘤内 CD8 T 细胞耗竭和对 PD-1 阻断治疗反应性的影响。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005293.
9
Autonomous rhythmic activity in glioma networks drives brain tumour growth.胶质瘤网络中的自主节律活动驱动脑肿瘤生长。
Nature. 2023 Jan;613(7942):179-186. doi: 10.1038/s41586-022-05520-4. Epub 2022 Dec 14.
10
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.新型胶质母细胞瘤肿瘤微环境亚型的鉴定、验证及生物学特征:对精准免疫治疗的意义
Ann Oncol. 2023 Mar;34(3):300-314. doi: 10.1016/j.annonc.2022.11.008. Epub 2022 Dec 6.